Posted by Michael Wonder on 16 Jan 2020
Why Canada won't end up as the drugstore to the U.S.
16 January 2020 - Although in theory the new U.S. import proposals could significantly affect Canadians and their drug supplies, their actual impact likely will be minimal.
The Trump administration’s proposal to allow imports of prescription drugs from Canada has met with objections from manufacturers and wholesalers and has also caused alarm among ordinary Canadians regarding potential supply shortages. Concerns are understandable. But in reality the plan likely will have little effect on Canadian drug supplies.
Last July, Washington announced the “Safe Importation Action Plan,” which would permit U.S. states, wholesalers, pharmacists and drug manufacturers to legally import eligible prescription drugs into the U.S. from Canada under specified conditions. In late December, the U.S. FDA invited comments on a proposed rule and draft guidance for the plan’s implementation.
